Health Canada Issues an Interim Order for Spectral Medical’s PMX to Treat COVID-19 Patients - Seite 3
The TSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this statement.
Lesen Sie auch
For further information, please contact:
Dr. Paul Walker President and CEO Spectral Medical Inc. 416-626-3233 ext. 2100 pwalker@spectraldx.com |
Mr. Chris Seto CFO Spectral Medical Inc. 416-626-3233 ext. 2004 cseto@spectraldx.com |
Ali Mahdavi Capital Markets & Investor Relations 416-962-3300 am@spinnakercmi.com |
Aktuelle Themen
Weitere Artikel des Autors
1 im Artikel enthaltener WertIm Artikel enthaltene Werte